Non-invasive Fat Reduction Market Worth US$ 3.75 Billion by 2030 - Growth Plus Reports
Growth Plus Reports
7 min read
Growth Plus Reports
Singapore, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global non-invasive fat reduction market is expected to clock US$ 3.75 billion by 2030 and to grow at a CAGR of 13.2% during the forecast period. This exclusive information is published by Growth Plus Reports in its report titled “Non-Invasive Fat Reduction Market – Global Outlook & Forecast 2022-2030”
Long and exhausting working hours, behavioral risk factors such as alcohol and cigarette usage, and stress, as well as an increased likelihood of maintaining a sedentary lifestyle, have all contributed to the advancement of illnesses such as diabetes and obesity. For instance, according to WHO’s September 2022 factsheet, the number of diabetes patients rose from 108 million to 422 million in the span of the years 1980-2014. People have started being more aware of their aesthetic appearance and look forward to less time-consuming procedures for fat loss, this will help in the growth of the global non-invasive fat reduction market. Additionally, new product launches, as well as approval for non-invasive fat reduction are also fueling the market growth. The development of non-invasive fat reduction technology such as cryolipolysis, ultrasound, and radiofrequency, has increased the popularity of these procedures and is also resulting in boosting the global non-invasive fat reduction market. The rise in cosmetic surgery acceptability in recent years has also aided the growth of the global non-invasive fat reduction industry. The advancement of non-invasive fat reduction technology, such as cryolipolysis, ultrasound, and radiofrequency, has raised the popularity of these operations, hence driving the global non-invasive fat reduction market.
The global non-invasive fat reduction market is analyzed from three perspectives: Technology, End User, and Region
Excerpts from ‘ByApplicationSegmentation’
Based on the technology, the global non-invasive fat reduction market is segmented into:
Ultrasound
Cryolipolysis
Low-Level Lasers
Others
Ultrasound is projected to be the fastest-growing segment throughout the forecast period. Ultrasound fat removal is a non-invasive cosmetic procedure used to reduce fat in specific areas of the body. It works by using high-frequency sound waves to destroy fat cells, which are then naturally eliminated from the body. The procedure is typically performed using a hand-held device that is applied to the skin, and it can target fat in areas such as the abdomen, thighs, hips, and arms. One of the main benefits of ultrasound fat removal is that it is a non-invasive procedure, so there is no need for incisions, stitches, or general anesthesia. This means that the recovery time is much faster than with traditional liposuction procedures, and there is a lower risk of complications. Additionally, ultrasound fat removal can produce significant results in reducing fat in specific areas, although multiple sessions may be required to achieve the desired outcome.
Excerpts from ‘ByEnd UserSegmentation’
Based on the end user, the global non-invasive fat reduction market is segmented into:
Hospitals
Stand-Alone Practices
Specialty Clinics
Home Care
Others
Due to the availability of modern technology and qualified medical practitioners, the specialty clinics segment is expected to be the fastest-growing segment over the forecast period. Specialty clinics often invest in cutting-edge technology and methods for non-invasive fat removal, allowing them to provide a variety of effective and efficient treatments. They have highly skilled and experienced medical specialists in non-invasive fat reduction techniques, who have the knowledge and skills to assist patients in achieving the finest results possible. Furthermore, specialist clinics provide tailored treatment by taking the time to understand each patient's unique requirements and goals. They can create a personalized treatment plan for each patient to assist them to accomplish their fat loss goals. These general factors all lead to the growth of the specialty clinics segment.
Geographically, the global non-invasive fat reduction market has been segmented into:
North America
Europe
Asia Pacific
Rest of the World
North America dominated the global non-invasive fat reduction market in 2021, owing to the rising obese population, adoption of new technologies, and constant awareness campaigns about health. Additionally, companies across the region are continuously working on bringing innovative and novel techniques for non-invasive fat reduction, which is also helping the regional market’s growth. For instance, in August 2022, AirSculpt Technologies, Inc., a nationwide supplier of body contouring operations, started offering their customers cutting-edge cellulite elimination with AirSculpt Smooth, a single, FDA-cleared, minimally invasive one-time procedure performed in combination with a normal AirSculpt procedure. The AirSculpt Smooth results completely eliminate obstinate cellulite dimples. AirSculpt Smooth uses no needles, scalpels, or sutures and is performed while the client is awake, allowing them to return to their normal activities in 24-48 hours.
Non-invasive Fat Reduction Market Scope
Report Attribute
Details
Market size value in 2021
US$ 1.23 billion
Revenue Forecast in 2030
US$ 3.75 billion
Growth Rate
CAGR of 13.2% from 2022 to 2030
Base year for estimation
2021
Forecast Year
2022-2030
Historical Year
2020
Segments Covered
Technology, End User, and Region
Regional Scope
North America, Europe, Asia Pacific, and the Rest of the World (ROW)
Excerpts from ‘Competitive Landscape’
Some prominent players operating in the global non-invasive fat reduction market are
Cynosure, LLC
Alma Lasers
Fotona
Solta Medical (Bausch Health Companies Inc.)
Lumenis Be Ltd.
El.En. S.p.A.
Cutera Inc.
Zeltiq Aesthetics
Candela Medical
Ambicare Health
Image Dermatology
Table of Content
INTRODUCTION
Market Ecosystem
Timeline Under Consideration
Historical Years – 2020
Base Year – 2021
Forecast Years – 2022 to 2030
Currency Used in the Report
RESEARCH METHODOLOGY
Research Approach
Data Collection Methodology
Data Sources
Secondary Sources
Primary Sources
Market Estimation Approach
Bottom Up
Top Down
Market Forecasting Model
Limitations and Assumptions
PREMIUM INSIGHTS
Current Market Trend (COVID-19 Perspective)
Key Players & Competitive Positioning (2021)
MARKET DYNAMICS
Drivers
Restraints/Challenges
Opportunities
GLOBAL NON-INVASIVE FAT REDUCTION MARKET- ANALYSIS & FORECAST, BY TECHNOLOGY
Ultrasound
Cryolipolysis
Low-Level Lasers
Others
GLOBAL NON-INVASIVE FAT REDUCTION MARKET- ANALYSIS & FORECAST, BY END-USER
Vagus Nerve Stimulation Market by Product (Implantable, External), Application (Migraine, Depression, Epilepsy, Others), Biomaterial (Polymer, Metallic, Ceramic), End-user (Hospital, Neurology Clinics, Ambulatory Surgical Centers) – Global Outlook & Forecast 2022-2030
Immune Thrombocytopenia Therapeutics Market by Type (Acute Immune Thrombocytopenia, Chronic Immune Thrombocytopenia), Therapy (Intravenous Immunoglobulin (IVIG), Corticosteroids), and Distribution Channel (Hospitals Pharmacy, Retail Pharmacy)-Global Outlook & Forecast 2022-2030
Hypopituitarism Diagnostics Market by Type (Isolated Pituitary Deficiency, Multiple Pituitary Hormone Deficiency), Test Type (Hormone Stimulation, MRI or CT scan), End User (Hospitals, Specialty Clinics, Academic Research Institutes) – Global Outlook & Forecast 2022-2030
Hand-Foot Syndrome Treatment Market by Drug Class (Analgesics, NSAID’s), Distribution Channel (Hospital Pharmacy, Online Pharmacy) – Global Outlook & Forecast 2022-2030
Global Fluoroscopy Equipment Market by Product (Fluoroscopy Systems and C-arms), Application (Cardiovascular, Pain Management & Trauma), and End User (Hospitals, Diagnostic Laboratories, and Specialty Clinics) – Global Outlook & Forecast 2022-2030
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.